BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 47 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $21,883,000 | -48.1% | 20,680,000 | -46.8% | 0.01% | -26.7% |
| Q4 2019 | $42,177,000 | +25.4% | 38,875,000 | +19.0% | 0.02% | +15.4% |
| Q3 2019 | $33,639,000 | -18.0% | 32,664,000 | -10.8% | 0.01% | -18.8% |
| Q2 2019 | $41,046,000 | +11.0% | 36,608,000 | +12.3% | 0.02% | 0.0% |
| Q1 2019 | $36,969,000 | +5.5% | 32,608,000 | +3.5% | 0.02% | -5.9% |
| Q4 2018 | $35,031,000 | -12.4% | 31,500,000 | -5.6% | 0.02% | 0.0% |
| Q3 2018 | $39,995,000 | +12.2% | 33,381,000 | +8.9% | 0.02% | +6.2% |
| Q2 2018 | $35,631,000 | +9.3% | 30,656,000 | +3.9% | 0.02% | +6.7% |
| Q1 2018 | $32,598,000 | +1629800.0% | 29,501,000 | +1474950.0% | 0.02% | – |
| Q4 2017 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | -100.0% | 2,000 | -100.0% | 0.00% | -100.0% |
| Q2 2017 | $21,944,000 | -6.0% | 18,425,000 | -6.8% | 0.01% | -15.4% |
| Q1 2017 | $23,337,000 | +11.8% | 19,767,000 | +12.4% | 0.01% | +18.2% |
| Q4 2016 | $20,878,000 | +2.6% | 17,592,000 | +7.8% | 0.01% | 0.0% |
| Q3 2016 | $20,351,000 | +12.2% | 16,322,000 | +4.0% | 0.01% | 0.0% |
| Q2 2016 | $18,144,000 | -24.7% | 15,692,000 | -22.9% | 0.01% | -26.7% |
| Q1 2016 | $24,089,000 | -11.9% | 20,348,000 | +0.2% | 0.02% | -16.7% |
| Q4 2015 | $27,337,000 | -2.5% | 20,298,000 | -2.2% | 0.02% | -14.3% |
| Q3 2015 | $28,036,000 | -14.0% | 20,758,000 | +0.5% | 0.02% | -8.7% |
| Q2 2015 | $32,618,000 | +15.3% | 20,658,000 | +10.8% | 0.02% | +15.0% |
| Q1 2015 | $28,297,000 | +81.3% | 18,638,000 | +46.3% | 0.02% | +100.0% |
| Q4 2014 | $15,612,000 | +9.6% | 12,738,000 | -2.1% | 0.01% | 0.0% |
| Q3 2014 | $14,249,000 | -14.9% | 13,013,000 | -18.1% | 0.01% | -9.1% |
| Q2 2014 | $16,737,000 | +7.2% | 15,893,000 | +13.0% | 0.01% | 0.0% |
| Q1 2014 | $15,615,000 | +76.6% | 14,068,000 | +70.1% | 0.01% | +83.3% |
| Q4 2013 | $8,842,000 | – | 8,268,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 5,000,000 | $5,003,000 | 2.71% |
| Weiss Asset Management LP | 65,841,000 | $64,360,000 | 2.62% |
| Davide Leone & Partners Investment Co Ltd. | 10,500,000 | $10,513,000 | 1.19% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 29,597,000 | $29,800,000 | 1.14% |
| GLAZER CAPITAL, LLC | 7,483,000 | $7,474,000 | 0.36% |
| BLUEFIN CAPITAL MANAGEMENT, LLC | 52,500 | $5,243,000 | 0.33% |
| OAKTREE CAPITAL MANAGEMENT LP | 13,428,000 | $13,444,000 | 0.29% |
| CSS LLC/IL | 5,500,000 | $5,498,000 | 0.26% |
| Kohlberg Kravis Roberts & Co. L.P. | 40,182,000 | $40,159,000 | 0.23% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,606,000 | $2,606,000 | 0.10% |